Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

National blood program in Korea.

K S Han1, S I Kim

  • 1Department of Clinical Pathology, Seoul National University College of Medicine, Korea. kshanmd@snuh.snu.ac.kr

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology
|March 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized phase III trial of anthracyclines followed by taxane versus taxane plus carboplatin as (neo)adjuvant therapy in patients with triple-negative breast cancer: KCSG BR 15-1 PEARLY trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

A prospective study for brain metastasis imaging screening in patients with advanced HER2-positive or triple-negative breast cancer.

ESMO open·2026
Same author

Managing hydrocephalus in 54 infants under 3 months of age: A single center cohort study.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2025
Same author

Body mass index at diagnosis of a childhood brain tumor; a reflection of hypothalamic-pituitary dysfunction or lifestyle?

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2022
Same author

Hemostats in Spine Surgery: Literature Review and Expert Panel Recommendations.

Neurospine·2022
Same author

The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Korea has met red cell and platelet needs through donations since 1980 but imports significant plasma. Efforts are underway to enhance blood safety, achieve plasma self-sufficiency, and improve quality assurance in blood banking.

Area of Science:

  • Blood banking and transfusion medicine.
  • Public health and national health policy.

Background:

  • South Korea has relied on voluntary donations for red blood cells and platelets since 1980.
  • Despite self-sufficiency in cellular blood products, the nation imports substantial plasma for fractionation.

Purpose of the Study:

  • To outline the current state of blood supply in Korea.
  • To highlight the challenges in plasma procurement and fractionation.
  • To detail ongoing initiatives for improving blood safety and quality.

Main Methods:

  • Analysis of national blood supply statistics.
  • Review of blood center operational models (Korean Red Cross and hospital-based).
  • Overview of current quality assurance and safety enhancement measures.

Related Experiment Videos

Main Results:

  • Voluntary donations fully meet red cell and platelet demands.
  • Annual plasma import volume reaches 300,000 liters for fractionation products.
  • The Korean Red Cross supplies 96% of blood, with hospitals providing the remaining 4%.

Conclusions:

  • While cellular blood product supply is stable, national plasma self-sufficiency remains a key objective.
  • Continuous improvement in blood safety, plasma sourcing, and quality assurance are critical for public health.
  • The current system relies heavily on the Korean Red Cross, with a smaller contribution from hospital blood centers.